16 Jul 2024 --- Scientists at microbiome in vivo gene editing pioneer Eligo Bioscience have demonstrated a way to genetically modify bacteria in the gut of animals. This lays the groundwork for strategies to better understand how genes from the microbiome drive disease and creates opportunities to develop new therapies.